Global Recombinant Human Insulin Industry 2015 Deep Market Research Report

Global Recombinant Human Insulin Industry 2015 Deep Market Research Report

Category : Diagnostic and Biotech
Published On : January  2015
Pages : 120



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Global Recombinant Human Insulin Industry 2015 Deep Market Research Report is a professional and depth research report on Global Recombinant Human Insulin industry. 

For overview analysis, the report introduces Recombinant Human Insulin basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

For international and China market analysis, the report analyzes Recombinant Human Insulin markets in China and other countries or regions (such as US, Russia, etc.) by presenting research on global products of different types and applications, developments and trends of market, technology, and competitive landscape, and leading suppliers and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included. 

For technical data and manufacturing plants analysis, the report analyzes Recombinant Human Insulin leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D Status, technology sources, and raw materials sources.

This report also presents product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. Analysis also covers upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals.

In the end, the report includes Recombinant Human Insulin new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis. In conclusion, it is a deep research report on Global Recombinant Human Insulin industry. Here, we express our thanks for the support and assistance from Recombinant Human Insulin industry chain related technical experts and marketing engineers during Research Team’s survey and interviews.

Chapter One Recombinant Human Insulin Industry Overview    1

1.1 Recombinant Human Insulin Definition    1

1.2 Recombinant Human Insulin Classification    2

1.3 Recombinant Human Insulin Industry Chain Structure    2

1.4 Recombinant Human Insulin Industry Overview    2

1.5 Recombinant Human Insulin Industry Policy Analysis    3

1.6 Recombinant Human Insulin Industry News Analysis    5



Chapter Two Recombinant Human Insulin International and China Market Analysis    7

2.1 Recombinant Human Insulin Industry International Market Analysis    7

2.1.1 Recombinant Human Insulin International Market Development History    7

2.1.2 Recombinant Human Insulin Product and Technology Developments    7

2.1.3 Recombinant Human Insulin International Competitive Landscape Analysis    9

2.1.4 Recombinant Human Insulin International Key Countries Development Status    10

2.1.5 Recombinant Human Insulin International Market Development Trend    11

2.2 Recombinant Human Insulin Industry China Market Analysis    11

2.2.1 Recombinant Human Insulin China Market Development History    11

2.2.2 Recombinant Human Insulin Product and Technology Developments    12

2.2.3 Recombinant Human Insulin China Competitive Landscape Analysis    13

2.2.4 Recombinant Human Insulin China Key Regions Development Status    14

2.2.5 Recombinant Human Insulin China Market Development Trend    15

2.3 Recombinant Human Insulin International and China Market Comparison Analysis    15



Chapter Three Recombinant Human Insulin Technical Data and Manufacturing Plants Analysis    16

3.1 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production    16

3.2 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources Analysis    16



Chapter Four Recombinant Human Insulin Major Countries Import Export Consumption    18

4.1 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption    18

4.2 2009-2014 India Recombinant Human Insulin Supply Import Export Consumption    18

4.3 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption    19

4.4 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption    19

4.5 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption    19

4.6 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption    20



Chapter Five Recombinant Human Insulin Manufacturing Process and Cost Structure    21

5.1 Recombinant Human Insulin Product Specifications    21

5.1.1 Novo Nordisk Recombinant Human Insulin Product Specifications    21

5.1.2 Lilly Recombinant Human Insulin Product Specifications    22

5.2 Recombinant Human Insulin Manufacturing Process Analysis    22

5.3 Recombinant Human Insulin Cost Structure Analysis    23

5.4 Recombinant Human Insulin Cost Analysis    24



Chapter Six 2009-2014 Recombinant Human Insulin Productions Supply Sales Demand Market Status and Forecast    25

6.1 2009-2014 Recombinant Human Insulin Capacity Production (Million Pcs) Overview    25

6.2 2009-2014 Recombinant Human Insulin Production Market Share Analysis    32

6.3 2009-2014 Recombinant Human Insulin Demand Overview    43

6.4 2009-2014 Recombinant Human Insulin Supply Demand and Shortage    45

6.5 2009-2014 Recombinant Human Insulin Import Export Consumption    45

6.6 2009-2014 Recombinant Human Insulin Cost Price Production Value Gross Margin    46



Chapter Seven Recombinant Human Insulin Key Manufacturers Analysis    47

7.1 Novo Nordisk    47

7.1.1 Company Profile    47

7.1.2 Novo Nordisk Recombinant Human Insulin Product Picture and Specification    50

7.1.3 Novo Nordisk Recombinant Human Insulin Capacity Production Price Cost Production Value    50

7.1.4 Contact Information    51

7.2 Eli Lilly    52

7.2.1 Company Profile    52

7.2.2 Eli Lilly Recombinant Human Insulin Product Picture and Specification    55

7.2.3 Eli Lilly Recombinant Human Insulin Capacity Production Price Cost Production Value    56

7.2.4 Contact Information    57

7.3 Bioton    59

7.3.1 Company Profile    59

7.3.2 Bioton Recombinant Human Insulin Product Picture and Specification    59

7.3.3 Bioton Recombinant Human Insulin Capacity Production Price Cost Production Value    62

7.3.4 Contact Information    63

7.4 Dongbao    64

7.4.1 Company Profile    64

7.4.2 Dongbao Recombinant Human Insulin Product Picture and Specification    65

7.4.3 Dongbao Recombinant Human Insulin Capacity Production Price Cost Production Value    68

7.4.4 Contact Information    69

7.5 United Laboratories (TUL)    69

7.5.1 Company Profile    69

7.5.2 United Laboratories Recombinant Human Insulin Product Picture and Specification    73

7.5.3 United Laboratories Recombinant Human Insulin Capacity Production Price Cost Production Value    75

7.5.4 Contact Information    76



Chapter Eight Up and Down Stream Industry Analysis    78

8.1 Upstream Raw Materials Price Analysis    78

8.2 Upstream Equipment Market Analysis    78

8.3 Down Stream Demand Analysis    80

8.4 Industry Chain Analysis    81



Chapter Nine Recombinant Human Insulin Marketing Channels Analysis    82

9.1 Recombinant Human Insulin Marketing Channels Status    82

9.2 Recombinant Human Insulin Marketing Channels Characteristic    82

9.3 Recombinant Human Insulin Marketing Channels Development Trend    83



Chapter Ten Recombinant Human Insulin Industry Development Trend    88

10.1 2015-2020 Recombinant Human Insulin Capacity Production Overview    88

10.2 2015-2020 Recombinant Human Insulin Production Market Share Analysis    90

10.3 2015-2020 Recombinant Human Insulin Demand Overview    94

10.4 2015-2020 Recombinant Human Insulin Supply Demand and Shortage    95

10.5 2015-2020 Recombinant Human Insulin Import Export Consumption    95

10.6 2015-2020 Recombinant Human Insulin Cost Price Production Value Gross Margin    96



Chapter Eleven Recombinant Human Insulin Industry Development Proposals    97

11.1 Macroeconomic Development Countermeasures    97

11.1.1 Macroeconomic policy    98

11.1.2 Specific control measures    99

11.2 New Firms Enter Market Strategy    100

11.3 New Project Investment Proposals    102

11.4 Marketing Channel Strategy Proposals    103

11.5 Competitive Environment Strategy Proposals    104



Chapter Twelve Recombinant Human Insulin New Project Investment Feasibility Analysis    105

12.1 Recombinant Human Insulin Project SWOT Analysis    105

12.2 Recombinant Human Insulin New Project Investment Feasibility Analysis    105

12.2.1 Project Name    105

12.2.2 Investment Budget    105

12.2.3 Project Schedule    106

12.2.4 Benefit Analysis of Project    106



Chapter Thirteen Global and China Recombinant Human Insulin Industry Research Conclusions    108



List of Tables and Figures



Figure Recombinant Human Insulin product picture    1

Table Recombinant Human Insulin Classification    2

Figure Recombinant Human Insulin Industry Chain Structure    2

Figure 2013 International Recombinant Human Insulin Major Manufacturers Production Share    9

Figure 2013 Recombinant Human Insulin International Key Countries Production Share    10

Figure 2015-2020 Recombinant Human Insulin International Capacity Production and Growth Rate    11

Figure 2013 Recombinant Human Insulin China Key Regions Production Share    13

Figure 2013 Recombinant Human Insulin China Key Regions Production Share    14

Figure 2015-2020 Recombinant Human Insulin China Capacity Production and Growth Rate    15

Figure 2009-2014 International and China Capacity Production Comparison    15

Table 2014 Global Key Insulin Manufacturing Plants Capacity and Commercial Production (Million Pcs) Date    16

Table 2014 Global Key Manufacturers Recombinant Human Insulin Raw Materials Sources List    16

Table 2009-2014 China Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)    18

Table 2009-2014 India Supply Import Export Consumption (Million Pcs)    18

Table 2009-2014 USA Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)    19

Table 2009-2014 France Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)    19

Table 2009-2014 Brazil Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)    19

Table 2009-2014 Russia Recombinant Human Insulin Supply Import Export Consumption (Million Pcs)    20

Figure Recombinant Human Insulin Manufacturing Process    23

Figure Recombinant Human Insulin Cost Structure Analysis    24

Figure Recombinant Human Insulin Cost Analysis    24

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List    25

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Capacity Market Share List    25

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List    26

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share List    26

Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    26

Table 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate List    26

Figure 2009-2014 Global Recombinant Human Insulin Capacity (Million Pcs) and Production Growth Rate    27

Figure 2009-2014 Global Recombinant Human Insulin Capacity Utilization Rate    27

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity and Total Capacity (Million Pcs) List    27

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Capacity Market Share List    28

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production and Total Production (Million Pcs) List    28

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Market Share List    28

Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    29

Table 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate List    29

Figure 2009-2014 China Recombinant Human Insulin Capacity and Production Growth Rate    29

Figure 2009-2014 China Recombinant Human Insulin Capacity Utilization Rate    30

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List    30

Table 2009-2014 Global Major Manufacturers Recombinant Human Insulin Production Value Market    30

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value (Million $) and Total Production Value List    31

Table 2009-2014 China Major Manufacturers Recombinant Human Insulin Production Value Market Share List    31

Figure 2009 Global Major Manufacturers Recombinant Human Insulin Production Market Share    32

Figure 2009 China Major Manufacturers Recombinant Human Insulin Production Market Share    33

Figure 2010 Global Major Manufacturers Recombinant Human Insulin Production Market Share    34

Figure 2010 China Major Manufacturers Recombinant Human Insulin Production Market Share    35

Figure 2011 Global Major Manufacturers Recombinant Human Insulin Production Market Share    36

Figure 2011 China Major Manufacturers Recombinant Human Insulin Production Market Share    37

Figure 2012 Global Major Manufacturers Recombinant Human Insulin Production Market Share    38

Figure 2012 China Major Manufacturers Recombinant Human Insulin Production Market Share    39

Figure 2013 Global Major Manufacturers Recombinant Human Insulin Production Market Share    40

Figure 2013 China Major Manufacturers Recombinant Human Insulin Production Market Share    41

Figure 2014 Global Major Manufacturers Recombinant Human Insulin Production Market Share    42

Figure 2014 China Major Manufacturers Recombinant Human Insulin Production Market Share    43

Table 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) List    43

Figure 2009-2014 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate    44

Table 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) List    44

Figure 2009-2014 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate    44

Table 2009-2014 Global Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List    45

Table 2009-2014 China Recombinant Human Insulin Demand Supply Shortage (Million Pcs) List    45

Table 2009-2014 China Recombinant Human Insulin Import Export Consumption (Million Pcs)    45

Table 2009-2014 Global Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    46

Table 2009-2014 China Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    46

Figure Novo Nordisk Network    48

Figure Novo Nordisk works with five strategic focus areas based on five core capabilities    48

Figure Global manufacturing setup    49

Figure Novo Nordisk’s position is protected by patents and value chain setup    49

Figure Novo Nordisk Recombinant Human Insulin Product Picture and Specification    50

Table 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    50

Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    51

Figure 2009-2014 Novo Nordisk Recombinant Human Insulin Production Global Market Share    51

Figure Eli Lilly Recombinant Human Insulin Product Picture and Specification    56

Table 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    56

Figure 2009-2014 Eli Lilly Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    57

Figure 2009-2014 Eli Lilly Recombinant Human Insulin Production Global Market Share    57

Figure Bioton Million Pcs Gensulin M30 Recombinant Human Insulin Product Picture and Specification    61

Table 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    62

Figure 2009-2014 Bioton Million Pcs Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    62

Figure 2009-2014 Bioton Recombinant Human Insulin Production Global Market Share    63

Figure Dongbao Gansulin R Recombinant Human Insulin Product Picture and Specification    65

Figure Dongbao Gansulin N Recombinant Human Insulin Product Picture and Specification    66

Figure Dongbao Gansulin 30R Recombinant Human Insulin Product Picture and Specification    67

Table 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    68

Figure 2009-2014 Dongbao Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    68

Figure 2009-2014 Dongbao Recombinant Human Insulin Production Global Market Share    69

Figure United Laboratories USLIN® N Recombinant Human Insulin Product Picture and Specification    73

Figure United Laboratories USLIN®50 Recombinant Human Insulin Product Picture and Specification    73

Figure United Laboratories USLIN®30 Recombinant Human Insulin Product Picture and Specification    74

Figure United Laboratories USLIN®R Recombinant Human Insulin Product Picture and Specification    74

Table 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) Price Cost Gross ($/Pcs) Production Value (Million $) Gross Margin List    75

Figure 2009-2014 United Laboratories Recombinant Human Insulin Capacity Production (Million Pcs) and Growth Rate    75

Figure 2009-2014 United Laboratories Recombinant Human Insulin Production Global Market Share    76

Figure Fermenter Picture    78

Figure Extraction system and Separation equipment    79

Figure Air purification systems    80

Figure Cold storage    80

Table 2009-2014 the Number of Diabetes (Million) and Diabetes Required Recombinant Human Insulin (Million) and Diabetes Growth Rate    81

Figure Recombinant Human Insulin Industry Chain    81

Figure Recombinant Human Insulin Marketing Channels Status    82

Table Recombinant Human Insulin Marketing Channels Characteristic Overview    82

Figure Marketing Channels Characteristic    83

Figure Flat Sales Channel Forms a Glance    84

Figure Partnership-type Relationship Sales Channels Form a Glance    86

Figure the export trend Overview    86

Figure 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate    88

Figure 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) and Growth Rate    89

Figure 2015 Global Recombinant Human Insulin Production Market Share    90

Figure 2020 Global Recombinant Human Insulin Production Market Share    91

Figure 2015 China Recombinant Human Insulin Production Market Share    92

Figure 2020 China Recombinant Human Insulin Production Market Share    93

Figure 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) and Growth Rate    94

Figure 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) and Growth Rate    94

Table 2015-2020 Global Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List    95

Table 2015-2020 China Recombinant Human Insulin Demand (Million Pcs) Supply (Million Pcs) Shortage (Million Pcs) List    95

Table 2015-2020 China Recombinant Human Insulin Import (Million Pcs) Export (Million Pcs) Consumption (Million Pcs)    95

Table 2015-2020 Global Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List    96

Table 2015-2020 China Recombinant Human Insulin Capacity (Million Pcs) Production (Million Pcs) Price ($/Pcs) Cost ($/Pcs) Gross ($/Pcs) Production Value (Million $) Gross Margin List    96

Table Macroeconomic Development Countermeasures Analysis    97

Table New Firms Enter Market Strategy    100

Table New Project Investment Proposals    102

Figure Recombinant Human Insulin Marketing strategy recommendations    103

Table Recombinant Human Insulin Marketing Channel Strategy Proposals    104

Table Competitive Environment Strategy Proposals    104

Table Recombinant Human Insulin Project SWOT Analysis    105

Table 100 Million Pcs Recombinant Human Insulin Project Appraisal and Financing    106

Table 100 Million Pcs Recombinant Human Insulin Project Construction Period    106

Table Annual Output of 100 Million Pcs Recombinant Human Insulin Project Return on Investment and Feasibility Analysis    106


Enquiry Before Buy
image
Can´t read the image ? refresh here.